-

Shareholder Alert: Robbins LLP is Investigating OneSpan Inc. (OSPN) for Shareholders

SAN DIEGO & CHICAGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP is investigating OneSpan Inc. (NASDAQ: OSPN) to determine whether certain OneSpan officers and directors violated the Securities Exchange Act of 1934 and breached their fiduciary duties to the Company. OneSpan and its subsidiaries design, develop, and market solutions for identity, security, and business productivity.

If you suffered a loss due to OneSpan Inc.'s misconduct, click here.

OneSpan Inc. (OSPN) Overstated its Revenue

OneSpan Inc. may have made false and misleading statements regarding the Company's internal policies and downplayed the likely negative impact on its profits. On August 4, 2020, OneSpan postponed its second quarter 2020 earnings release due to revenue recognition problems spanning from the first quarter of 2018 through the first quarter of 2020, "which caused overstatements of revenue." After market close on August 11, 2020, the Company announced that it would not be able to timely submit its SEC report for the quarter ending on June 30, 2020, that same quarter year-over-year revenues had declined, and withdrew its full year 2020 earnings guidance, which it had just confirmed one quarter earlier. On this news, the Company stock price fell almost 40% to close at $18.84 per share on August 12, 2020.

OneSpan Inc. (OSPN) Shareholders Have Options

Contact us to learn more:
Lauren Levi
(800) 350-6003
llevi@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. To be notified if a class action against OneSpan Inc. settles or to receive free alerts about companies engaged in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Lauren Levi
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Stockholder Notice: Robbins LLP Informs Investors of the Atara Biotherapeutics, Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Atara Biotherapeutics, Inc. (NASDAQ: ATRA) securities between May 20, 2024 and January 9, 2026. Atara develops therapies for patients with solid tumors, hematologic cancers, and autoimmune diseases in the U.S. and the United Kingdom (“U.K.”). The Company’s lead product candidate is tabelecleucel (also referred to as tab-cel or EBVALLO), a T-ce...

Stockholder Notice: Robbins LLP Informs Investors of the Coty Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Coty Inc. (NYSE: COTY) common stock between November 5, 2025 and February 4, 2026. Coty together with its subsidiaries, manufactures, markets, distributes, and sells branded beauty products worldwide. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Inves...

Investor Notice: Robbins LLP Informs Investors of the Lufax Holding Ltd. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Lufax Holding Ltd. (NYSE: LU) securities between April 7, 2023 and January 26, 2025. Lufax Holding Ltd engages in the retail credit and enablement business to borrowers and institutions in China. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigat...
Back to Newsroom